TIMP1 and colorectal carcinoma: Yang et al. found that TIMP metallopeptidase inhibitor 1 (TIMP1) mRNA levels were higher in platelets from patients with CRC compared to those from healthy volunteers or patients with inflammatory bowel diseases, which may prove to be another helpful signature [34].